Carlos Brito, Ph.D., is an Associate Director of Clinical Design at Eli Lilly and Company, where they lead the design and delivery of scientifically rigorous and patient-centered trials in the cardiometabolic health portfolio. Previously, they contributed to the cytogenetic characterization of clinical samples at the Universidad Nacional de Colombia and conducted research on mosquito proteases at Purdue University, culminating in a Ph.D. focused on flavivirus maturation. With a foundation in immunology and drug development, Carlos is dedicated to advancing medicines that significantly impact patient health.
This person is not in the org chart
This person is not in any teams
This person is not in any offices